Accendra Health (ACH) Common Equity (2009 - 2026)

Accendra Health (ACH) has reported Common Equity for 18 consecutive years, with -$550.9 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Common Equity fell 96.06% year-over-year to -$550.9 million in Q2 2026; TTM through Jun 2026 was -$550.9 million, a 96.06% decrease from a year earlier, with the FY2025 full-year figure at -$461.0 million, down 178.62% from the prior year.
• Common Equity was -$550.9 million for Q2 2026 at Accendra Health, down from -$464.8 million in the prior quarter.
• Over five years, Common Equity peaked at $966.8 million in Q3 2022 and troughed at -$550.9 million in Q2 2026.
• A 5-year average of $508.7 million and a median of $891.3 million in 2023 frame the typical range for Common Equity.
• Across the five-year window, Common Equity increased 20.52% in 2022 and slumped 181.4% in 2026, its largest moves.
• Over 5 years, Common Equity stood at $966.7 million in 2022, then dropped by 2.22% to $945.3 million in 2023, then slumped by 37.97% to $586.4 million in 2024, then sank by 178.62% to -$461.0 million in 2025, then dropped by 19.52% to -$550.9 million in 2026.
• The last three Common Equity figures came in at -$550.9 million (Q2 2026), -$464.8 million (Q1 2026), and -$461.0 million (Q4 2025), per Business Quant data.